Forkhead transcription factors: Key players in health and disease

Trends in Genetics

Volumn 27, Issue 6, 2011, Pages 224-232

  Benayoun, Bérénice A ^a,b   Caburet, Sandrine ^a,b   Veitia, Reiner A ^a,b  

^a INSTITUT JACQUES MONOD   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; WINGED HELIX TRANSCRIPTION FACTOR;

AGING; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CHROMATIN STRUCTURE; DIMERIZATION; GENE CONTROL; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC DISORDER; HUMAN; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

AGING; ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 79956294799     PISSN: 01689525     EISSN: 01689525     Source Type: Journal    
DOI: 10.1016/j.tig.2011.03.003     Document Type: Review

References (107)

1. Weigel D., et al. The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 1989, 57:645-658.
2. Carlsson P., Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev. Biol. 2002, 250:1-23.
3. Kaestner K.H., et al. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 2000, 14:142-146.
4. Hannenhalli S., Kaestner K.H. The evolution of Fox genes and their role in development and disease. Nat. Rev. Genet. 2009, 10:233-240.
5. Wotton K.R., Shimeld S.M. Comparative genomics of vertebrate Fox cluster loci. BMC Genomics 2006, 7:271.
6. Larroux C., et al. Genesis and expansion of metazoan transcription factor gene classes. Mol. Biol. Evol. 2008, 25:980-996.
7. Baron D., et al. An evolutionary and functional analysis of FoxL2 in rainbow trout gonad differentiation. J. Mol. Endocrinol. 2004, 33:705-715.
8. Clark K.L., et al. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 1993, 364:412-420.
9. Obsil T., Obsilova V. Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene 2008, 27:2263-2275.
10. Cirillo L.A., Zaret K.S. Specific interactions of the wing domains of FOXA1 transcription factor with DNA. J. Mol. Biol. 2007, 366:720-724.
11. Georges A.B., et al. Generic binding sites, generic DNA-binding domains: where does specific promoter recognition come from?. FASEB J. 2010, 24:346-356.
12. Romanelli M.G., et al. Nuclear localization domains in human thyroid transcription factor 2. Biochim. Biophys. Acta 2003, 1643:55-64.
13. Hancock W.W., Ozkaynak E. Three distinct domains contribute to nuclear transport of murine Foxp3. PLoS ONE 2009, 4:e7890.
14. Watkins W.J., et al. An investigation into FOXE1 polyalanine tract length in premature ovarian failure. Mol. Hum. Reprod. 2006, 12:145-149.
15. Zhao Y., et al. Association between FOXP2 gene and speech sound disorder in Chinese population. Psychiatry Clin. Neurosci. 2010, 64:565-573.
16. Moumne L., et al. Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development. Hum. Mol. Genet. 2008, 17:1010-1019.
17. Gersak K., et al. A novel 30bp deletion in the FOXL2 gene in a phenotypically normal woman with primary amenorrhoea: case report. Hum. Reprod. 2004, 19:2767-2770.
18. Caburet S., et al. A genomic basis for the evolution of vertebrate transcription factors containing amino acid runs. Genetics 2004, 167:1813-1820.
19. Tsai K.L., et al. Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification. Nucleic Acids Res. 2007, 35:6984-6994.
20. Tsai K.L., et al. Crystal structure of the human FOXK1a-DNA complex and its implications on the diverse binding specificity of winged helix/forkhead proteins. J. Biol. Chem. 2006, 281:17400-17409.
21. Stroud J.C., et al. Structure of the forkhead domain of FOXP2 bound to DNA. Structure 2006, 14:159-166.
22. Seoane J., et al. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 2004, 117:211-223.
23. Madureira P.A., et al. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J. Biol. Chem. 2006, 281:25167-25176.
24. Blount A.L., et al. FoxL2 and Smad3 coordinately regulate follistatin gene transcription. J. Biol. Chem. 2009, 284:7631-7645.
25. van der Vos K.E., Coffer P.J. FOXO-binding partners: it takes two to tango. Oncogene 2008, 27:2289-2299.
26. Dansen T.B., et al. Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat. Chem. Biol. 2009, 5:664-672.
27. Kitamura Y.I., et al. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2005, 2:153-163.
28. Calnan D.R., Brunet A. The FoxO code. Oncogene 2008, 27:2276-2288.
29. Greer E.L., et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 2007, 282:30107-30119.
30. Tan Y., et al. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol. Cell. Biol. 2007, 27:1007-1016.
31. Li B., et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:4571-4576.
32. Benayoun B.A., et al. Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations. Hum. Mol. Genet. 2009, 18:632-644.
33. Yamagata K., et al. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol. Cell 2008, 32:221-231.
34. Caldwell S.A., et al. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 2010, 29:2831-2842.
35. Ho S.R., et al. O-GlcNAcylation enhances FOXO4 transcriptional regulation in response to stress. FEBS Lett. 2010, 584:49-54.
36. van der Horst A., et al. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol. 2006, 8:1064-1073.
37. Brent M.M., et al. Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification. Structure 2008, 16:1407-1416.
38. Benayoun B.A., Veitia R.A. A post-translational modification code for transcription factors: sorting through a sea of signals. Trends Cell Biol. 2009, 19:189-197.
39. Lehmann O.J., et al. Fox's in development and disease. Trends Genet. 2003, 19:339-344.
40. Wang B., et al. Analysis of FOXO3 mutation in 114 Chinese women with premature ovarian failure. Reprod. Biomed. Online 2010, 20:499-503.
41. Laissue P., et al. Functional evidence implicating FOXL2 in non syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. J. Med. Genet. 2009, 46:455-457.
42. Hamdan F.F., et al. De novo mutations in FOXP1 in Cases with intellectual disability, autism, and language impairment. Am. J. Hum. Genet. 2010, 87:671-678.
43. Horn D., et al. Identification of FOXP1 deletions in three unrelated patients with mental retardation and significant speech and language deficits. Hum. Mutat. 2010, 31:E1851-E1860.
44. Ariani F., et al. FOXG1 is responsible for the congenital variant of Rett syndrome. Am. J. Hum. Genet. 2008, 83:89-93.
45. Bahi-Buisson N., et al. Revisiting the phenotype associated with FOXG1 mutations: two novel cases of congenital Rett variant. Neurogenetics 2010, 11:241-249.
46. Beausejour C.M., Campisi J. Ageing: balancing regeneration and cancer. Nature 2006, 443:404-405.
47. Salih D.A., Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr. Opin. Cell Biol. 2008, 20:126-136.
48. Paik J.H., et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007, 128:309-323.
49. Flachsbart F., et al. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2700-2705.
50. Willcox B.J., et al. FOXO3A genotype is strongly associated with human longevity. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13987-13992.
51. Anselmi C.V., et al. Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res. 2009, 12:95-104.
52. Li Y., et al. Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations. Hum. Mol. Genet. 2009, 18:4897-4904.
53. Panowski S.H., et al. PHA-4/Foxa mediates diet-restriction-induced longevity of C. elegans. Nature 2007, 447:550-555.
54. Le Lay J., Kaestner K.H. The Fox genes in the liver: from organogenesis to functional integration. Physiol. Rev. 2010, 90:1-22.
55. Laoukili J., et al. FoxM1: at the crossroads of ageing and cancer. Biochim. Biophys. Acta 2007, 1775:92-102.
56. Wang X., et al. Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:11468-11473.
57. Gallardo T.D., et al. Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrhea. Hum. Reprod. 2008, 23:216-221.
58. Belikov S., et al. FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptor-regulated promoter. Mol. Cell. Biol. 2009, 29:5413-5425.
59. Kwon H.K., et al. Foxp3 induces IL-4 gene silencing by affecting nuclear translocation of NFkappaB and chromatin structure. Mol. Immunol. 2008, 45:3205-3212.
60. Cuesta I., et al. The forkhead factor FoxE1 binds to the thyroperoxidase promoter during thyroid cell differentiation and modifies compacted chromatin structure. Mol. Cell. Biol. 2007, 27:7302-7314.
61. Yan J., et al. The forkhead transcription factor FoxI1 remains bound to condensed mitotic chromosomes and stably remodels chromatin structure. Mol. Cell. Biol. 2006, 26:155-168.
62. Hatta M., et al. Acetylation curtails nucleosome binding, not stable nucleosome remodeling, by FoxO1. Biochem. Biophys. Res. Commun. 2009, 379:1005-1008.
63. Hatta M., Cirillo L.A. Chromatin opening and stable perturbation of core histone:DNA contacts by FoxO1. J. Biol. Chem. 2007, 282:35583-35593.
64. Ottolenghi C., et al. Foxl2 is required for commitment to ovary differentiation. Hum. Mol. Genet. 2005, 14:2053-2062.
65. Uhlenhaut N.H., et al. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 2009, 139:1130-1142.
66. Batista F., et al. Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:3330-3335.
67. Astorga J., Carlsson P. Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4. Development 2007, 134:3753-3761.
68. Ormestad M., et al. Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 2006, 133:833-843.
69. Madison B.B., et al. FoxF1 and FoxL1 link hedgehog signaling and the control of epithelial proliferation in the developing stomach and intestine. J. Biol. Chem. 2009, 284:5936-5944.
70. Katoh M. Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog TGFbeta and Notch signaling cascades. Int. J. Mol. Med. 2009, 23:763-769.
71. Wolfrum C., et al. Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:11624-11629.
72. Sanchez-Calderon H., et al. RNA microarray analysis in prenatal mouse cochlea reveals novel IGF-I target genes: implication of MEF2 and FOXM1 transcription factors. PLoS ONE 2010, 5:e8699.
73. Essers M.A., et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 2004, 23:4802-4812.
74. Wu Z., et al. MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice. J. Clin. Invest. 2010, 120:3901-3911.
75. Behren A., et al. Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion. Oncogene 2010, 29:1519-1530.
76. Cui Q., et al. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1 Lef1 and CBP. Oncogene 2005, 24:3864-3874.
77. Grainger J.R., et al. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. J. Exp. Med. 2010, 207:2331-2341.
78. Jana S., et al. The role of NF-kappaB and Smad3 in TGF-beta-mediated Foxp3 expression. Eur. J. Immunol. 2009, 39:2571-2583.
79. Pogoda H.M., et al. The zebrafish forkhead transcription factor FoxH1/Fast1 is a modulator of nodal signaling required for organizer formation. Curr. Biol. 2000, 10:1041-1049.
80. Myatt S.S., Lam E.W. The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer 2007, 7:847-859.
81. Ottolenghi C., et al. Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. Hum. Mol. Genet. 2007, 16:2795-2804.
82. Hu B., et al. Control of hair follicle cell fate by underlying mesenchyme through a CSL-Wnt5a-FoxN1 regulatory axis. Genes Dev. 2010, 24:1519-1532.
83. Moreno L.M., et al. FOXE1 association with both isolated cleft lip with or without cleft palate, and isolated cleft palate. Hum. Mol. Genet. 2009, 18:4879-4896.
84. Shoichet S.A., et al. Haploinsufficiency of novel FOXG1B variants in a patient with severe mental retardation, brain malformations and microcephaly. Hum. Genet. 2005, 117:536-544.
85. Uda M., et al. Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum. Mol. Genet. 2004, 13:1171-1181.
86. Shu W., et al. Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development 2007, 134:1991-2000.
87. Wang B., et al. Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development 2004, 131:4477-4487.
88. Feuk L., et al. Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia. Am. J. Hum. Genet. 2006, 79:965-972.
89. Shu W., et al. Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9643-9648.
90. Fujita E., et al. Ultrasonic vocalization impairment of Foxp2 (R552H) knockin mice related to speech-language disorder and abnormality of Purkinje cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3117-3122.
91. Tomblin J.B., et al. Language features in a mother and daughter of a chromosome 7;13 translocation involving FOXP2. J. Speech Lang. Hear. Res. 2009, 52:1157-1174.
92. Adesina A.M., et al. FOXG1 dysregulation is a frequent event in medulloblastoma. J. Neurooncol. 2007, 85:111-122.
93. Chan D.W., et al. Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer. Br. J. Cancer 2009, 101:1433-1443.
94. Adesina A.M., et al. FOXG1 is overexpressed in hepatoblastoma. Hum. Pathol. 2007, 38:400-409.
95. Kim J.H., et al. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W). Oncogene 2010, 10.1038/onc.2010.541.
96. Benayoun B.A., et al. Transcription factor FOXL2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylase. Hum. Mol. Genet. 2011, 10.1093/hmg/ddr042.
97. Benayoun B.A., et al. The forkhead factor FOXL2: a novel tumor suppressor?. Biochim. Biophys. Acta 2010, 1805:1-5.
98. Samaan G., et al. Foxn3 is essential for craniofacial development in mice and a putative candidate involved in human congenital craniofacial defects. Biochem. Biophys. Res. Commun. 2010, 400:60-65.
99. Markowski J., et al. Metal-proteinase ADAM12, kinesin 14 and checkpoint suppressor 1 as new molecular markers of laryngeal carcinoma. Eur. Arch. Otorhinolaryngol. 2009, 266:1501-1507.
100. Chang J.T., et al. Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): overexpression of NPM CDK1 and NDRG1 and underexpression of CHES1. Int. J. Cancer 2005, 114:942-949.
101. Pehlivan D., et al. Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas. J. Cancer Res. Clin. Oncol. 2008, 134:1267-1276.
102. Katoh H., et al. Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. Gastroenterology 2007, 133:1475-1486.
103. Greer E.L., Brunet A. FOXO transcription factors in ageing and cancer. Acta Physiol. 2008, 192:19-28.
104. Bates G.J., et al. Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas. Breast Cancer Res. Treat. 2008, 111:453-459.
105. Brown P.J., et al. Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL. Blood 2008, 111:2816-2824.
106. Mercer F., Unutmaz D. The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer. Adv. Exp. Med. Biol. 2009, 665:47-59.
107. Wang L., et al. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell 2009, 16:336-346.